Rapid Shift from SARS-CoV-2 Delta to Omicron Sub-Variants within a Dynamic Southern U.S. Borderplex
Viruses,
Journal Year:
2023,
Volume and Issue:
15(3), P. 658 - 658
Published: Feb. 28, 2023
COVID-19,
caused
by
the
Severe
Acute
Respiratory
Syndrome
Coronavirus
2
(SARS-CoV-2),
remains
an
ongoing
global
health
challenge.
This
study
analyzed
3641
SARS-CoV-2
positive
samples
from
El
Paso,
Texas,
community
and
hospitalized
patients
over
48
weeks
Fall
2021
to
Summer
2022.
The
binational
along
U.S.
southern
border
was
predominantly
Delta
variant
(B.1.617.2)
for
a
5-week
period
September
January
2022
quickly
transitioned
Omicron
(B.1.1.529),
which
first
detected
at
end
of
December
2021.
replaced
as
predominant
detectable
in
associated
with
sharp
increase
COVID-19
positivity
rate,
related
hospitalizations,
newly
reported
cases.
In
this
study,
BA.1,
BA.4,
BA.5
variants
were
overwhelmingly
S-gene
dropout
qRT-PCR
analysis
unlike
BA.2
variants.
reveals
that
dominant
variant,
like
Delta,
can
be
rapidly
more
transmissible
Omicron,
within
dynamic
metropolitan
city,
necessitating
enhanced
monitoring,
readiness,
response
public
officials
healthcare
workers.
Language: Английский
S-Gene Target Failure as an Effective Tool for Tracking the Emergence of Dominant SARS-CoV-2 Variants in Switzerland and Liechtenstein, Including Alpha, Delta, and Omicron BA.1, BA.2, and BA.4/BA.5
Dominique Hilti,
No information about this author
Faina Wehrli,
No information about this author
Sabine Berchtold
No information about this author
et al.
Microorganisms,
Journal Year:
2024,
Volume and Issue:
12(2), P. 321 - 321
Published: Feb. 3, 2024
During
the
SARS-CoV-2
pandemic,
Dr.
Risch
medical
group
employed
multiplex
TaqPathTM
COVID-19
CE-IVD
RT-PCR
Kit
for
large-scale
routine
diagnostic
testing
in
Switzerland
and
principality
of
Liechtenstein.
The
TaqPath
is
a
widely
used
assay
targeting
three
genes
(i.e.,
ORF1AB,
N,
S).
With
emergence
B.1.1.7
(Alpha)
variant,
flaw
became
apparent
as
amplification
S-gene
target
was
absent
these
samples
due
to
deletion
(ΔH69/V70)
Alpha
variant
genome.
This
failure
(SGTF)
earliest
indication
new
emerging
also
observed
subsequent
variants
such
Omicron
BA.1
BA4/BA.5.
Delta
BA.2
did
not
present
with
SGTF.
From
September
2020
November
2022,
we
investigated
applicability
SGTF
surrogate
marker
B.1.1.7,
B.1.617.2
(Delta),
BA.1,
BA.2,
BA.4/BA.5
cycle
threshold
(Ct)
values
<
30.
Next
true
SGTF-positive
SGTF-negative
samples,
there
were
presenting
delayed-type
(higher
Ct
value
than
ORF1ab
gene).
Among
these,
difference
3.8
between
S-
found
best
distinguish
“true”
variability
assay.
Samples
above
cutoff
subsequently
termed
partial
(pSGTF).
Variant
confirmation
performed
by
whole-genome
sequencing
(Oxford
Nanopore
Technology,
Oxford,
UK)
or
mutation-specific
PCR
(TIB
MOLBIOL).
In
total,
17,724
(7.4%)
among
240,896
positives
variant-confirmed,
resulting
an
overall
sensitivity
specificity
93.2%
[92.7%,
93.7%]
99.3%
[99.2%,
99.5%],
respectively.
Sensitivity
increased
98.2%
[97.9%
98.4%]
lowered
98.9%
[98.6%
99.1%]
when
pSGTF
included.
Furthermore,
weekly
logistic
growth
rates
(α)
sigmoid’s
midpoint
(t0)
calculated
based
on
data
significantly
differ
from
calculations
comprehensive
GISAID.
therefore
allowed
valid
real-time
estimate
introduction
all
dominant
Language: Английский
Detection of SARS-CoV-2 Variants via Different Diagnostics Assays Based on Single-Nucleotide Polymorphism Analysis
Diagnostics,
Journal Year:
2023,
Volume and Issue:
13(9), P. 1573 - 1573
Published: April 27, 2023
Severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
is
characterized
by
fast
evolution
with
the
appearance
of
several
variants.
Next-Generation
Sequencing
(NGS)
technology
considered
gold
standard
for
monitoring
known
and
new
SARS-CoV-2
However,
complexity
this
renders
approach
impracticable
in
laboratories
located
areas
limited
resources.
We
analyzed
capability
ThermoFisher
TaqPath
COVID-19
RT-PCR
(TaqPath)
Seegene
Novaplex
Variant
assay
(Novaplex)
to
detect
Omicron
variants;
Allplex
VariantII
(Allplex)
was
also
evaluated
Delta
Sanger
sequencing
(SaS)
reference
method.
The
results
obtained
n
=
355
nasopharyngeal
samples
were:
negative
TaqPath,
although
positive
other
qualitative
molecular
assays
(n
35);
undetermined
40)
both
assays;
∆69/70
mutation
confirmed
as
variant
via
SaS
100);
BA.1
80);
typed
BA.2
80).
27.5%
11.4%
100%
were
subtypes.
In
total,
99/100
a
per
cent
agreement
(PPA)
98%
compared
SaS.
As
undermined
showed
RdRp
median
Ct
values
(Ct
35.4)
statistically
higher
than
those
(median
value
22.0;
p
<
0.0001,
Mann–Whitney
test),
inability
establish
variants
probably
linked
low
viral
load.
No
amplification
among
all
35
samples.
Overall,
20%
which
or
them,
twelve
not
even
SaS,
but
they
instead
correctly
identified
Novaplex.
Although
full-genome
remains
elected
method
characterize
strains,
our
data
show
high
ability
SNP-based
identify
VOCs,
resolving
TaqPath.
Language: Английский
Precision health diagnostic and surveillance network uses S gene target failure (SGTF) combined with sequencing technologies to track emerging SARS‐CoV‐2 variants
Immunity Inflammation and Disease,
Journal Year:
2022,
Volume and Issue:
10(6)
Published: May 11, 2022
The
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
pandemic
revealed
a
worldwide
lack
of
effective
molecular
surveillance
networks
at
local,
state,
and
national
levels,
which
are
essential
to
identify,
monitor,
limit
viral
community
spread.
SARS-CoV-2
variants
concern
(VOCs)
such
as
Alpha
Omicron,
show
increased
transmissibility
immune
evasion,
rapidly
became
dominant
VOCs
worldwide.
Our
objective
was
develop
an
evidenced-based
genomic
algorithm,
combining
reverse
transcription
polymerase
chain
reaction
(RT-PCR)
sequencing
technologies
quickly
identify
highly
contagious
VOCs,
before
cases
accumulate
exponentially.
Deidentified
data
were
obtained
from
508,969
patients
tested
for
disease
2019
(COVID-19)
with
the
TaqPath
COVID-19
RT-PCR
Combo
Kit
(ThermoFisher)
in
four
CLIA-certified
clinical
laboratories
Puerto
Rico
(n
=
86,639)
three
United
States
422,330).
frequency
S
Gene
Target
Failure
(SGTF)
>
47%
last
week
March
2021
both,
US
laboratories.
monthly
SGTF
steadily
exponentially
4%
November
2020
2021.
weekly
rate
samples
high
(>8%)
late
December
early
January
then
also
through
April
(48%).
exponential
increase
SGFT
prevalence
concurrent
sharp
among
all
sequences
uploaded
Global
Influenza
Surveillance
Response
System
(GISAID)
461).
variant
<1%
51.5%
collected
According
proposed
evidence-based
approximately
50%
should
be
managed
self-quarantine
contact
tracing
protocols,
while
WGS
confirms
their
lineage
results
suggest
this
workflow
is
useful
tracking
SGTF.
Language: Английский
Comparison of analytical performance and economic value of two biosurveillance methods for tracking SARS-COV-2 variants of concern
Nicholas P. Pinkhover,
No information about this author
Kerriann M. Pontbriand,
No information about this author
Kelli P. Fletcher
No information about this author
et al.
Microbiology Spectrum,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Jan. 11, 2024
ABSTRACT
The
development
of
biosurveillance
programs
with
strong
analytical
performance
and
economically
accessible
protocols
is
essential
for
monitoring
viral
pathogens.
Throughout
the
COVID-19
pandemic,
whole-genome
sequencing
(WGS)
has
been
prevailing
technology
SARS-CoV-2
variant
concern
(VOC)
detection.
While
WGS
offers
benefits,
it
a
lengthy
process,
financially
technically
straining
scalable
tracking.
aim
this
study
was
to
compare
economic
feasibility
PCR
mutation
panels
distinguishing
six
known
VOCs:
Alpha
(B.1.1.7
Q.4),
Gamma
(P.1),
Delta
(B.1.617.2
AY.4.2),
Omicron.
(B.1.1.529.1).
In
all,
78
SARS-CoV-2-positive
samples
were
collected
from
April
December
2021
at
Northeastern
University
(Cabot
Testing
Site,
Boston,
MA,
USA)
genotyping
analysis.
MagMax
Viral/Pathogen
II
Nucleic
Acid
Isolation
TaqPath
Combo
Kits
used
RNA
extraction
confirmation.
VOC
discrimination
assessed
using
two
TaqMan
single
nucleotide
polymorphism
(SNP)
assay
layouts,
Ion
Torrent
WGS.
November
2021,
panel
demonstrated
marked
versatility
by
detecting
emerging
Omicron
reported
South
Africa.
SNP
analysis
yielded
following
identifications:
B.1.1.7
(
N
=
20),
Q.4
3),
P.1
1),
B.1.617.2
30),
AY.4.2
B.1.1.529.1
20)
one
undetermined
1)
sample.
Genotyping
designated
lineages
in
77
samples,
46/78
confirmed
WGS,
while
32
failed
lineage
assignment.
RT-PCR
offer
pronounced
throughput
sensitivity
provide
an
advantageous
technique
biosurveillance.
IMPORTANCE
results
presented
our
manuscript
demonstrate
how
value
simplistic
reliable
molecular
assays
coupled
core
scientific
principle
standardization
can
be
overlooked
charm
more
sophisticated
instrumentation.
This
effect
often
amplified
during
tumultuous
public
health
events,
such
as
pandemic.
By
adapting
standardized
detect
prominently
circulating
variants,
we
able
better
assess
potential
impacts
rising
positivity
rates
transmission
clusters
within
population.
several
literature
publications
utilizing
NGS
have
similar
scope
ours,
many
investigations
lack
sufficiently
bioinformatics
inclusionary/exclusionary
criteria
identification.
Finally,
benefits
would
allow
global
implementation
biosurveillance,
rather
than
reserving
developed
nations.
Language: Английский
To Analyze the Sensitivity of RT-PCR Assays Employing S Gene Target Failure with Whole Genome Sequencing Data during Third Wave by SARS-CoV-2 Omicron Variant
Pooja Patel,
No information about this author
Yogita Mistry,
No information about this author
Monika Patel
No information about this author
et al.
Advances in Microbiology,
Journal Year:
2024,
Volume and Issue:
14(05), P. 247 - 255
Published: Jan. 1, 2024
Introduction:
Omicron
is
a
highly
divergent
variant
of
concern
(VOCs)
severe
acute
respiratory
syndrome
SARS-CoV-2.
It
carries
high
number
mutations
in
its
spike
protein
hence;
it
more
transmissible
the
community
by
immune
evasion
mechanisms.
Due
to
mutation
within
S
gene,
most
variants
have
reported
gene
target
failure
(SGTF)
with
some
commercially
available
PCR
kits.
Such
diagnostic
features
can
be
used
as
markers
screen
Omicron.
However,
Whole
Genome
Sequencing
(WGS)
only
gold
standard
approach
confirm
novel
microorganisms
at
genetically
level
similar
also
found
other
that
are
circulating
low
frequencies
worldwide.
This
Retrospective
study
aimed
assess
RT-PCR
sensitivity
detection
comparison
whole
genome
sequencing
detect
Methods:
We
analysed
retrospective
data
SARS-CoV-2
positive
samples
for
TaqPath
COVID-19
Combo
Kit
(ThermoFisher)
and
combined
technologies
emerged
pattern
during
third
wave
tertiary
care
centre,
Surat.
Results:
From
first
day
December
2021
till
end
February
2022,
total
321,803
tests
were
performed,
which
20,566
cases
our
centre
an
average
cumulative
positivity
6.39%
over
period
three
months.
In
month
21
characterized
SGTF
(70/129)
suggestive
being
infected
identified
(B.1.1.529
lineage)
when
sequence.
January,
we
subset
(n
=
618)
(24%)
without
(76%)
Ct
values
Conclusions:
During
pandemic,
took
almost
than
15
days
diagnose
infection
identify
pathogen
technology.
contrast
molecular
assay
provided
quick
identification
help
phenomenon
5
hours
duration.
strategy
helps
scientists
health
policymakers
isolation
clusters.
That
ultimately
results
decreased
transmission
among
community.
Language: Английский
Evaluation of self‐collected nasal, urine, and saliva samples for molecular detection of SARS‐CoV‐2 using an EUA approved RT‐PCR assay and a laboratory developed LAMP SARS‐CoV‐2 test
Immunity Inflammation and Disease,
Journal Year:
2024,
Volume and Issue:
12(6)
Published: June 1, 2024
Abstract
As
the
SARS‐CoV‐2
virus
spread
throughout
world,
millions
of
positive
cases
COVID‐19
were
registered
and,
even
though
there
are
people
already
vaccinated
against
SARS‐CoV‐2,
a
large
part
global
population
remains
vulnerable
to
contracting
virus.
Massive
nasopharyngeal
sample
collection
in
Puerto
Rico
at
beginning
pandemic
was
limited
by
scarcity
trained
personnel
and
testing
sites.
To
increase
molecular
availability,
we
evaluated
diagnostic
accuracy
self‐collected
nasal,
saliva,
urine
samples
using
TaqPath
reverse
transcription
polymerase
chain
reaction
(RT‐PCR)
kit
detect
SARS‐CoV‐2.
We
also
created
colorimetric
loop‐mediated
isothermal
amplification
(LAMP)
laboratory
developed
test
(LDT)
as
another
strategy
availability
community‐based
laboratories.
Automated
RNA
extraction
performed
KingFisher
Flex
instrument,
followed
PCR
quantification
on
7500
Fast
Dx
RT‐PCR
test.
Data
interpreted
Interpretive
Software
from
Applied
Biosystems
statistically
analyzed
with
Cohen's
kappa
coefficient
(k).
(k)
for
paired
nasal
saliva
showed
moderate
agreement
(0.52).
Saliva
exhibited
higher
viral
load.
observed
90%
concordance
between
LifeGene‐Biomarks'
Rapid
Colorimetric
LAMP
LDT
Our
results
suggest
that
is
superior
testing.
The
rapid
alternative
tests
detection
This
can
be
easily
implemented
clinics,
hospitals,
workplace,
home;
optimizing
surveillance
process,
which
helps
mitigate
public
health
socioeconomic
upheaval
caused
airborne
pandemics.
Language: Английский